| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Mrz―10 |
Computational electrostatic engineering of nanobodies for enhanced SARS-CoV-2 receptor binding domain recognition |
Zafar Iqbal, Muhammad Asim, Umair Ahmad Khan, Neelam Sultan, Irfan Ali |
| 2 |
[GO] |
2025―Feb―27 |
Pilot study: a descriptive-retrospective analysis of SARS-CoV-2 variants distribution and phylogenesis in the Phlegraean area |
Maria Cristina Mazzarella, Stefano Cristiano, Dilia Rea, Nicola Mazzarella, Martina Addeo, Silvia Iannelli, Geppino Falco, Mariarita Brancaccio, Tiziana Angrisano |
| 3 |
[GO] |
2025―Feb―25 |
Development of an enzyme-linked immunosorbent assay (ELISA) for determining neutrophil elastase (NE) - a potential useful marker of multi-organ damage observed in COVID-19 and post-Covid-19 (PCS) |
Joanna Adamiec-Mroczek, Joanna Kluz, Sandra Chwałek, Maciej Rabczyński, Kinga Gostomska-Pampuch, Łukasz Lewandowski, Marta Misiuk-Hojło, Beata Ponikowska, Goutam Chourasia, Ilias Dumas, Andrzej Gamian, Żanna Fiodorenko-Dumas, Bogusława Konopska, Agnieszka Gola, Klaudia Konikowska, Daniel Strub, Agnieszka Bronowicka-Szydełko, Katarzyna Madziarska |
| 4 |
[GO] |
2025―Feb―11 |
Simulations of pH and thermal effects on SARS-CoV-2 spike glycoprotein |
Ziyuan Niu, Georgios Kementzidis, Miriam Rafailovich, Marcia Simon, Evangelos Papadopoulos, Bertal H. Aktas, Yuefan Deng |
| 5 |
[GO] |
2025―Jan―06 |
The role of neutrophilia in hyperlactatemia, blood acidosis, impaired oxygen transport, and mortality outcome in critically ill COVID-19 patients |
Basma A. Yasseen, Aya A. Elkhodiry, Hajar El-sayed, Mona Zidan, Azza G. Kamel, Mohamed A. Badawy, Marwa S. Hamza, Riem M. El-Messiery, Mohamed El Ansary, Engy A. Abdel-Rahman, Sameh S. Ali |
| 6 |
[GO] |
2024―Nov―20 |
Serum beta2-microglobulin and peripheral blood eosinophils for the assessment of severity and prognosis with omicron variant COVID-19 infection |
Jie Tan, Hanxi Fang, Xiao Hu, Ming Yue, Junling Yang |
| 7 |
[GO] |
2024―Sep―09 |
Exploring metabolic anomalies in COVID-19 and post-COVID-19: a machine learning approach with explainable artificial intelligence |
Juan José Oropeza-Valdez, Cristian Padron-Manrique, Aarón Vázquez-Jiménez, Xavier Soberon, Osbaldo Resendis-Antonio |
| 8 |
[GO] |
2024―Sep―06 |
A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis |
Asma Fatima, Anupriya M. Geethakumari, Wesam S. Ahmed, Kabir H. Biswas |
| 9 |
[GO] |
2024―Aug―23 |
Cross comparison of alternative diagnostic protocols including substitution to the clinical sample, RNA extraction method and nucleic acid amplification technology for COVID-19 diagnosis |
Ismael Segura-Ulate, Navilla Apú, Bernal Cortés, Jordi Querol-Audi, Yamitzel Zaldívar, Carlos Alexander Ortega, Fernando Flores-Mora, Andrés Gatica-Arias, Germán Madrigal-Redondo |
| 10 |
[GO] |
2024―Jul―08 |
Network-based integrative multi-omics approach reveals biosignatures specific to COVID-19 disease phases |
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, Darren P. Martin, Emile R. Chimusa, Peter A. C. ’t Hoen |
| 11 |
[GO] |
2024―Jun―12 |
Computational design and investigation of the monomeric spike SARS-CoV-2-ferritin nanocage vaccine stability and interactions |
Farnaz Garmeh Motlagh, Maryam Azimzadeh Irani, Seyedeh Zeinab Masoomi Nomandan, Mohammad Assadizadeh |
| 12 |
[GO] |
2024―Mai―23 |
Performance evaluation of a SARS-CoV-2 and influenza A/B combo rapid antigen test |
Kevin P. Rosenblatt, Hugo Romeu, Camille Romeu, Elder Granger |
| 13 |
[GO] |
2024―Mrz―28 |
Electrophysiological properties and structural prediction of the SARS-CoV-2 viroprotein E |
Salvatore Antonio Maria Cubisino, Stefan Milenkovic, Stefano Conti-Nibali, Nicolò Musso, Paolo Bonacci, Vito De Pinto, Matteo Ceccarelli, Simona Reina |
| 14 |
[GO] |
2024―Mrz―27 |
Modeling of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-2 considering the protein flexibility by using molecular dynamics and cross-docking |
Jorge Luis Valdés-Albuernes, Erbio Díaz-Pico, Sergio Alfaro, Julio Caballero |
| 15 |
[GO] |
2024―Mrz―07 |
Integrating virtual screening, pharmacoinformatics profiling, and molecular dynamics: identification of promising inhibitors targeting 3CLpro of SARS-CoV-2 |
Abeer Mohammad, Ahmed Zheoat, Amjad Oraibi, Ajay Manaithiya, Khalid S. Almaary, Hiba Allah Nafidi, Mohammed Bourhia, Soumaya Kilani-Jaziri, Yousef A. Bin Jardan |
| 16 |
[GO] |
2024―Feb―05 |
Virus sequencing performance during the SARS-CoV-2 pandemic: a retrospective analysis of data from multiple rounds of external quality assessment in Austria |
Jeremy V. Camp, Elisabeth Puchhammer-Stöckl, Stephan W. Aberle, Christoph Buchta |
| 17 |
[GO] |
2024―Jan―18 |
Investigation of protein-protein interactions and hotspot region on the NSP7-NSP8 binding site in NSP12 of SARS-CoV-2 |
José Xavier Lima Neto, Katyanna Sales Bezerra, Emmanuel Duarte Barbosa, Roniel Lima Araujo, Douglas Soares Galvão, Marcelo Leite Lyra, Jonas Ivan Nobre Oliveira, Shopnil Akash, Yousef A. Bin Jardan, Hiba-Allah Nafidi, Mohammed Bourhia, Umberto Laino Fulco |
| 18 |
[GO] |
2024―Jan―11 |
The analysis of low-dose glucocorticoid maintenance therapy in patients with primary nephrotic syndrome suffering from COVID-19 |
Yong-Qi Li, Min Wu, Yu-Jia Wang, Yu-Xia Zhang, Jing Lu, Yi-Nan Zhao, Bo-Fan Ji, Zhi-Qing Chen, Ri-Ning Tang, Bi-Cheng Liu |
| 19 |
[GO] |
2024―Jan―05 |
Design of protein-binding peptides with controlled binding affinity: the case of SARS-CoV-2 receptor binding domain and angiotensin-converting enzyme 2 derived peptides |
Giacomo Parisi, Roberta Piacentini, Alessio Incocciati, Alessandra Bonamore, Alberto Macone, Jakob Rupert, Elsa Zacco, Mattia Miotto, Edoardo Milanetti, Gian Gaetano Tartaglia, Giancarlo Ruocco, Alberto Boffi, Lorenzo Di Rienzo |
| 20 |
[GO] |
2023―Nov―29 |
Oligomer formation of SARS-CoV-2 ORF8 through 73YIDI76 motifs regulates immune response and non-infusion antiviral interactions |
Mohammad Assadizadeh, Maryam Azimzadeh Irani |
| 21 |
[GO] |
2023―Nov―15 |
A comparative NMR-based metabolomics study of lung parenchyma of severe COVID-19 patients |
Joaquín I. Hurtado, Andrés López-Radcenco, José Luis Izquierdo-García, Fernando Rodríguez, Guillermo Moyna, Gonzalo Greif, Nicolás Nin |
| 22 |
[GO] |
2023―Nov―02 |
Structural understanding of SARS-CoV-2 virus entry to host cells |
Kim Le, Shrute Kannappan, Truc Kim, Jung Heon Lee, Hye-Ra Lee, Kyeong Kyu Kim |
| 23 |
[GO] |
2023―Okt―31 |
Corrigendum: VIDIIA Hunter: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostic platform approved for medical use in the UK |
Aurore C. Poirier, Ruben D. Riaño Moreno, Leona Takaindisa, Jessie Carpenter, Jai W. Mehat, Abi Haddon, Mohammed A. Rohaim, Craig Williams, Peter Burkhart, Chris Conlon, Matthew Wilson, Matthew McClumpha, Anna Stedman, Guido Cordoni, Manoharanehru Branavan, Mukunthan Tharmakulasingam, Nouman S. Chaudhry, Nicolas Locker, Anil Fernando, Wamadeva Balachandran, Mark Bullen, Nadine Collins, David Rimer, Daniel L. Horton, Muhammad Munir, Roberto M. La Ragione |
| 24 |
[GO] |
2023―Okt―10 |
Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review |
Pavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi |
| 25 |
[GO] |
2023―Okt―09 |
Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 on metabolic unhealthy obese patients |
Tengda Huang, Nan Jiang, Yujia Song, Hongyuan Pan, Ao Du, Bingxuan Yu, Xiaoquan Li, Jinyi He, Kefei Yuan, Zhen Wang |
| 26 |
[GO] |
2023―Okt―06 |
Cryo-electron microscopy in the fight against COVID-19-mechanism of virus entry |
Satish Bodakuntla, Christopher Cyrus Kuhn, Christian Biertümpfel, Naoko Mizuno |
| 27 |
[GO] |
2023―Okt―04 |
Clinical analysis of prolonged viral clearance time in patients with lymphoma combined with novel coronavirus infection |
Ying Li, Chao Wu, Liming Fei, Qin Xu, Xianru Shao, Bangjie Chen, Gengyun Sun |
| 28 |
[GO] |
2023―Sep―29 |
VIDIIA Hunter diagnostic platform: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostics approved for medical use in the UK |
Aurore C. Poirier, Ruben D. Riaño Moreno, Leona Takaindisa, Jessie Carpenter, Jai W. Mehat, Abi Haddon, Mohammed A. Rohaim, Craig Williams, Peter Burkhart, Chris Conlon, Matthew Wilson, Matthew McClumpha, Anna Stedman, Guido Cordoni, Manoharanehru Branavan, Mukunthan Tharmakulasingam, Nouman S. Chaudhry, Nicolas Locker, Anil Fernando, Wamadeva Balachandran, Mark Bullen, Nadine Collins, David Rimer, Daniel L. Horton, Muhammad Munir, Roberto M. La Ragione |
| 29 |
[GO] |
2023―Sep―11 |
SARS-CoV-2 infection as a potential risk factor for the development of cancer |
Natalia Ogarek, Paulina Oboza, Magdalena Olszanecka-Glinianowicz, Piotr Kocelak |
| 30 |
[GO] |
2023―Sep―01 |
Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease |
Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa, Fatma Hilal Yagin, Nagwan Abdel Samee, Noha F. Mahmoud |
| 31 |
[GO] |
2023―Aug―17 |
Editorial: The upcoming complications of COVID-19 on recovered patients: molecular mechanisms and therapeutic opportunities, volume II |
Seyed Hassan Seradj, William C. Cho, Zohreh Amoozgar, Rana Jahanban-Esfahlan |
| 32 |
[GO] |
2023―Aug―02 |
Editorial: Impact of SARS-CoV-2 on Antibiotic Resistance: Evolution of Treatment and Control Strategies |
Sanket Kaushik, Vijay Kumar Srivastava, Biswajit Mishra |
| 33 |
[GO] |
2023―Jun―27 |
Differences in the organization of interface residues tunes the stability of the SARS-CoV-2 spike-ACE2 complex |
Mattia Miotto, Lorenzo Di Rienzo, Greta Grassmann, Fausta Desantis, Gianluca Cidonio, Giorgio Gosti, Marco Leonetti, Giancarlo Ruocco, Edoardo Milanetti |
| 34 |
[GO] |
2023―Jun―24 |
Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking |
Luis Castillo-Campos, José Luis Velázquez-Libera, Julio Caballero |
| 35 |
[GO] |
2023―Jun―19 |
Bioinformatic and systems biology approach revealing the shared genes and molecular mechanisms between COVID-19 and non-alcoholic hepatitis |
Huishuang Lu, Jiaxiu Ma, Yalan Li, Jin Zhang, Yaxin An, Wei Du, Xuefei Cai |
| 36 |
[GO] |
2023―Jun―14 |
COVID-19 and brain-heart-lung microbial fingerprints in Italian cadavers |
Gulnaz T. Javan, Sheree J. Finley, Matteo Moretti, Silvia D. Visonà, Melissa P. Mezzari, Robert L. Green |
| 37 |
[GO] |
2023―Jun―14 |
A CRISPR-based approach using dead Cas9-sgRNA to detect SARS-CoV-2 |
Mustapha Aouida, Maryam Saifaldeen, Dana E. Al-Ansari, Sara Taleb, Ali Ait Hssain, Dindial Ramotar |
| 38 |
[GO] |
2023―Jun―13 |
Glycosylation of H4 influenza strains with pandemic potential and susceptibilities to lung surfactant SP-D |
Lisa M. Parsons, Olga Zoueva, Gabrielle Grubbs, Ewan Plant, Ewa Jankowska, Yijia Xie, Hao Song, George F. Gao, Zhiping Ye, Surender Khurana, John F. Cipollo |
| 39 |
[GO] |
2023―Jun―01 |
PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection |
V. S. Lekshmi, Kumari Asha, Melvin Sanicas, Abhila Asi, U. M. Arya, Binod Kumar |
| 40 |
[GO] |
2023―Apr―26 |
Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets |
Grace Kenny, Liam Townsend, Stefano Savinelli, Patrick W. G. Mallon |
| 41 |
[GO] |
2023―Mrz―16 |
G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters |
Shuvra Shekhar Roy, Shalu Sharma, Zaigham Abbas Rizvi, Dipanjali Sinha, Divya Gupta, Mercy Rophina, Paras Sehgal, Srikanth Sadhu, Manas Ranjan Tripathy, Sweety Samal, Souvik Maiti, Vinod Scaria, Sridhar Sivasubbu, Amit Awasthi, Krishnan H. Harshan, Sanjeev Jain, Shantanu Chowdhury |
| 42 |
[GO] |
2023―Mrz―16 |
Evolution of Indian Influenza A (H1N1) Hemagglutinin Strains: A Comparative Analysis of the Pandemic Californian HA Strain |
Shilpa Sri Pushan, Mahesh Samantaray, Muthukumaran Rajagopalan, Amutha Ramaswamy |
| 43 |
[GO] |
2023―Mrz―13 |
Super-infection by multiple microorganisms in COVID-19 patients |
Andrea C. Gomez, Tamin Ortiz, Angélica Valenzuela, Rocío Egoávil-Espejo, Rosario Huerto-Huanuco, Joseph A. Pinto, Jose Lagos, Joaquim Ruiz |
| 44 |
[GO] |
2023―Mrz―09 |
Editorial: Antiviral drug discovery against pathogens of pandemic concern: Advancements in target site identification and structure-based drug development |
Krishna M. Padmanabha Das |
| 45 |
[GO] |
2023―Mrz―07 |
Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation |
Abdus Samad, Amar Ajmal, Arif Mahmood, Beenish Khurshid, Ping Li, Syed Mansoor Jan, Ashfaq Ur Rehman, Pei He, Ashraf N. Abdalla, Muhammad Umair, Junjian Hu, Abdul Wadood |
| 46 |
[GO] |
2023―Feb―15 |
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19 |
Chiara Bruzzone, Ricardo Conde, Nieves Embade, José M. Mato, Oscar Millet |
| 47 |
[GO] |
2023―Feb―03 |
Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic |
Vikram Kumar, Nusrath Yasmeen, Anis Ahmad Chaudhary, Abdullah S. Alawam, Mohammed Al-Zharani, Nosiba Suliman Basher, S. Harikrishnan, Muddapuram Deeksha Goud, Aishwarya Pandey, Sudarshan Singh Lakhawat, Pushpender Kumar Sharma |
| 48 |
[GO] |
2023―Jan―11 |
Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis |
Fernando Dos Santos, Joyce B. Li, Nathalia Juocys, Rafi Mazor, Laura Beretta, Nicole G. Coufal, Michael T. Y. Lam, Mazen F. Odish, Maria Claudia Irigoyen, Anthony J. O’Donoghue, Federico Aletti, Erik B. Kistler |
| 49 |
[GO] |
2022―Dez―16 |
Identification and mechanistic basis of non-ACE2 blocking neutralizing antibodies from COVID-19 patients with deep RNA sequencing and molecular dynamics simulations |
Alger M. Fredericks, Kyle W. East, Yuanjun Shi, Jinchan Liu, Federica Maschietto, Alfred Ayala, William G. Cioffi, Maya Cohen, William G. Fairbrother, Craig T. Lefort, Gerard J. Nau, Mitchell M. Levy, Jimin Wang, Victor S. Batista, George P. Lisi, Sean F. Monaghan |
| 50 |
[GO] |
2022―Okt―25 |
Translocation pause of remdesivir-containing primer/template RNA duplex within SARS-CoV-2’s RNA polymerase complexes |
Yuanjun Shi, Jimin Wang, Victor S. Batista |
| 51 |
[GO] |
2022―Okt―21 |
Reduced platelet mitochondrial respiration and oxidative phosphorylation in patients with post COVID-19 syndrome are regenerated after spa rehabilitation and targeted ubiquinol therapy |
Zuzana Sumbalová, Jarmila Kucharská, Zuzana Rausová, Patrik Palacka, Eleonóra Kovalčíková, Timea Takácsová, Viliam Mojto, Plácido Navas, Guillermo Lopéz-Lluch, Anna Gvozdjáková |
| 52 |
[GO] |
2022―Okt―21 |
Corrigendum: ACE2 in the gut: The center of the 2019-nCoV infected pathology |
Yuexin Guo, Boya Wang, Han Gao, Lei Gao, Rongxuan Hua, Jing-Dong Xu |
| 53 |
[GO] |
2022―Okt―19 |
Corrigendum: Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex |
Wesam S. Ahmed, Angelin M. Philip, Kabir H. Biswas |
| 54 |
[GO] |
2022―Okt―10 |
Corrigendum: Targeting the N-terminus domain of the coronavirus nucleocapsid protein induces abnormal oligomerization via allosteric modulation |
Jia-Ning Hsu, Jyun-Siao Chen, Shan-Meng Lin, Jhen-Yi Hong, Yi-Jheng Chen, U-Ser Jeng, Shun-Yuan Luo, Ming-Hon Hou |
| 55 |
[GO] |
2022―Okt―10 |
Refinement of SARS-CoV-2 envelope protein structure in a native-like environment by molecular dynamics simulations |
Rui Yang, Sijin Wu, Shen Wang, Grace Rubino, Jonathan D. Nickels, Xiaolin Cheng |
| 56 |
[GO] |
2022―Sep―28 |
Improvement of native structure-based peptides as efficient inhibitors of protein-protein interactions of SARS-CoV-2 spike protein and human ACE2 |
Norbert Odolczyk, Joanna Klim, Małgorzata Podsiadła-Białoskórska, Maria Winiewska-Szajewska, Ewa Szolajska, Urszula Zielenkiewicz, Jarosław Poznański, Piotr Zielenkiewicz |
| 57 |
[GO] |
2022―Sep―27 |
Modeling of the thermal properties of SARS-CoV-2 S-protein |
Ziyuan Niu, Karin Hasegawa, Yuefan Deng, Ziji Zhang, Miriam Rafailovich, Marcia Simon, Peng Zhang |
| 58 |
[GO] |
2022―Sep―26 |
Cytoplasmic tail determines the membrane trafficking and localization of SARS-CoV-2 spike protein |
Qinlin Li, Yihan Liu, Leiliang Zhang |
| 59 |
[GO] |
2022―Sep―14 |
In-silico investigation of systematic missense mutations of middle east respiratory coronavirus spike protein |
Raina Rhoades, Adebiyi Sobitan, Vidhyanand Mahase, Brhan Gebremedhin, Qiyi Tang, Danda Rawat, Hongbao Cao, Shaolei Teng |
| 60 |
[GO] |
2022―Aug―16 |
Assessing the suitability of long non-coding RNAs as therapeutic targets and biomarkers in SARS-CoV-2 infection |
Yichen Zhong, Caroline L. Ashley, Megan Steain, Sandro Fernandes Ataide |
| 61 |
[GO] |
2022―Aug―15 |
Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants |
Adrianne L. Gelbach, Fuming Zhang, Seok-Joon Kwon, John T. Bates, Andrew P. Farmer, Jonathan S. Dordick, Chunyu Wang, Robert J. Linhardt |
| 62 |
[GO] |
2022―Aug―11 |
Host cell stress response as a predictor of COVID-19 infectivity and disease progression |
Celine Caillet, Melissa Louise Stofberg, Victor Muleya, Addmore Shonhai, Tawanda Zininga |
| 63 |
[GO] |
2022―Jul―22 |
Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex |
Wesam S. Ahmed, Angelin M. Philip, Kabir H. Biswas |
| 64 |
[GO] |
2022―Jul―19 |
Identification of COVID-19-Specific Immune Markers Using a Machine Learning Method |
Hao Li, Feiming Huang, Huiping Liao, Zhandong Li, Kaiyan Feng, Tao Huang, Yu-Dong Cai |
| 65 |
[GO] |
2022―Jul―12 |
Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike |
Yajuan Li, Peiyi Zheng, Tingting Liu, Cuixiao Shi, Bo Wang, Yuanhong Xu, Tengchuan Jin |
| 66 |
[GO] |
2022―Jun―30 |
An Altered Metabolism in Leukocytes Showing in vitro igG Memory From SARS-CoV-2-Infected Patients |
G. Fanelli, F. Gevi, G. Zarletti, M. Tiberi, V. De Molfetta, G. Scapigliati, A. M. Timperio |
| 67 |
[GO] |
2022―Jun―28 |
Detection of SARS-CoV-2 Genome in Stool and Plasma Samples of Laboratory Confirmed Iranian COVID-19 Patients |
Mobin Makhmalbaf, Seyed Masoud Hosseini, Hamid Asadzadeh Aghdaei, Mahsa Saeedi Niasar, Shahrzad Shoraka, Abbas Yadegar, Shaghayegh Baradaran Ghavami, Shabnam Shahrokh, Mohammadreza Moshari, Habib Malekpour, Mohammad Reza Zali, Seyed Reza Mohebbi |
| 68 |
[GO] |
2022―Jun―28 |
Evaluation of Clove Phytochemicals as Potential Antiviral Drug Candidates Targeting SARS-CoV-2 Main Protease: Computational Docking, Molecular Dynamics Simulation, and Pharmacokinetic Profiling |
Arun Chandra Manivannan, Arunkumar Malaisamy, Murugesh Eswaran, Arun Meyyazhagan, Vijaya Anand Arumugam, Kannan R. R. Rengasamy, Balamuralikrishnan Balasubramanian, Wen-Chao Liu |
| 69 |
[GO] |
2022―Jun―22 |
Editorial: Interaction of Biomolecules and Bioactive Compounds With the SARS-CoV-2 Proteins: Molecular Simulations for the Fight Against Covid-19 |
Mattia Falconi, James Leland Olds, Arvind Ramanathan |
| 70 |
[GO] |
2022―Jun―09 |
Clinical and Gene Features of SARS-CoV-2-Positive Recurrence in Patients Recovered From COVID-19 |
Yuying Peng, Shaoqi Wang, Ruihuan Chai, Yong Chen, Nan Li, Boning Zeng, Qian Tang, Kai Zheng, Youfang Liang, Shouxia Xie, Wei Huang, Shaoxiang Wang, Xiao Wang |
| 71 |
[GO] |
2022―Mai―23 |
Editorial: The Upcoming Complications of COVID-19 on Recovered Patients: Molecular Mechanisms and Therapeutic Opportunities |
Rana Jahanban-Esfahlan, Seyed Hassan Seradj, Zohreh Amoozgar, William C. Cho |
| 72 |
[GO] |
2022―Mai―23 |
Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding |
Abdullah Hoter, Hassan Y. Naim |
| 73 |
[GO] |
2022―Mai―20 |
Shape Complementarity Optimization of Antibody-Antigen Interfaces: The Application to SARS-CoV-2 Spike Protein |
Alfredo De Lauro, Lorenzo Di Rienzo, Mattia Miotto, Pier Paolo Olimpieri, Edoardo Milanetti, Giancarlo Ruocco |
| 74 |
[GO] |
2022―Mai―19 |
Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment |
Narjes Riahi Kashani, Javid Azadbakht, Hassan Ehteram, Hamed Haddad Kashani, Hassan Rajabi-Moghadam, Ejaz Ahmad, Hossein Nikzad, Elahe Seyed Hosseini |
| 75 |
[GO] |
2022―Mai―13 |
Dysregulated Exosomes Result in Suppression of the Immune Response of Pregnant COVID-19 Convalescent Women |
Hang Cao, Nor Haslinda Abd Aziz, Janet Raja Xavier, Mohamad Nasir Shafiee, Aida Kalok, Babban Jee, Madhuri S. Salker, Yogesh Singh |
| 76 |
[GO] |
2022―Mai―11 |
Phase Separation Drives SARS-CoV-2 Replication: A Hypothesis |
Andrea Vandelli, Giovanni Vocino, Gian Gaetano Tartaglia |
| 77 |
[GO] |
2022―Mai―10 |
Identifying Methylation Signatures and Rules for COVID-19 With Machine Learning Methods |
Zhandong Li, Zi Mei, Shijian Ding, Lei Chen, Hao Li, Kaiyan Feng, Tao Huang, Yu-Dong Cai |
| 78 |
[GO] |
2022―Mai―10 |
Potential of Natural Alkaloids From Jadwar (Delphinium denudatum) as Inhibitors Against Main Protease of COVID-19: A Molecular Modeling Approach |
Anuj Kumar, Mansi Sharma, Christopher D. Richardson, David J. Kelvin |
| 79 |
[GO] |
2022―Apr―29 |
Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug |
Bo Zhang, Junjie Tian, Qintao Zhang, Yan Xie, Kejia Wang, Shuyi Qiu, Keyu Lu, Yang Liu |
| 80 |
[GO] |
2022―Apr―27 |
Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19 |
Yongting Zhang, Fan Shi, Yuchong Wang, Yuting Meng, Qiong Zhang, Kaihang Wang, Ping Zeng, Hongyan Diao |
| 81 |
[GO] |
2022―Apr―19 |
Targeting the N-Terminus Domain of the Coronavirus Nucleocapsid Protein Induces Abnormal Oligomerization via Allosteric Modulation |
Jia-Ning Hsu, Jyun-Siao Chen, Shan-Meng Lin, Jhen-Yi Hong, Yi-Jheng Chen, U-Ser Jeng, Shun-Yuan Luo, Ming-Hon Hou |
| 82 |
[GO] |
2022―Apr―14 |
Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities |
Parastoo Hosseini, Mohammad Sadegh Fallahi, Gisou Erabi, Majid Pakdin, Seyed Mahdi Zarezadeh, Arezoo Faridzadeh, Sarina Entezari, Arina Ansari, Mohadeseh Poudineh, Niloofar Deravi |
| 83 |
[GO] |
2022―Apr―11 |
Serum NMR Profiling Reveals Differential Alterations in the Lipoproteome Induced by Pfizer-BioNTech Vaccine in COVID-19 Recovered Subjects and Naïve Subjects |
Veronica Ghini, Laura Maggi, Alessio Mazzoni, Michele Spinicci, Lorenzo Zammarchi, Alessandro Bartoloni, Francesco Annunziato, Paola Turano |
| 84 |
[GO] |
2022―Apr―01 |
A Rapid, Highly Sensitive and Open-Access SARS-CoV-2 Detection Assay for Laboratory and Home Testing |
Max J. Kellner, James J. Ross, Jakob Schnabl, Marcus P. S. Dekens, Martin Matl, Robert Heinen, Irina Grishkovskaya, Benedikt Bauer, Johannes Stadlmann, Luis Menéndez-Arias, Andrew D. Straw, Robert Fritsche-Polanz, Marianna Traugott, Tamara Seitz, Alexander Zoufaly, Manuela Födinger, Christoph Wenisch, Johannes Zuber, Andrea Pauli, Julius Brennecke |
| 85 |
[GO] |
2022―Mrz―31 |
Corrigendum: Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies |
Pek Yoon Chong, Jabed Iqbal, Joe Yeong, Tar Choon Aw, Kian Sing Chan, Paul Chui |
| 86 |
[GO] |
2022―Mrz―29 |
The Molecular Basis of the Effect of Temperature on the Structure and Function of SARS-CoV-2 Spike Protein |
Faez Iqbal Khan, Kevin A. Lobb, Dakun Lai |
| 87 |
[GO] |
2022―Mrz―28 |
Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection |
Jiahao Huang, Jing Wang, Yan Li, Ziyuan Wang, Ming Chu, Yuedan Wang |
| 88 |
[GO] |
2022―Mrz―28 |
Antigen-Antibody Complex-Guided Exploration of the Hotspots Conferring the Immune-Escaping Ability of the SARS-CoV-2 RBD |
Kit-Man Fung, Shu-Jung Lai, Tzu-Lu Lin, Tien-Sheng Tseng |
| 89 |
[GO] |
2022―Mrz―14 |
Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (Mpro) as Potential COVID-19 Therapies |
Sakshi Piplani, Puneet Singh, Nikolai Petrovsky, David A. Winkler |
| 90 |
[GO] |
2022―Mrz―14 |
Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites |
Ying Sheng, Anita Vinjamuri, Michael Russelle S. Alvarez, Yixuan Xie, Marisa McGrath, Siyu Chen, Mariana Barboza, Matthew Frieman, Carlito B. Lebrilla |
| 91 |
[GO] |
2022―Mrz―11 |
Exploring New Characteristics: Using Deep Learning and 3D Reconstruction to Compare the Original COVID-19 and Its Delta Variant Based on Chest CT |
Na Bai, Ruikai Lin, Zhiwei Wang, Shengyan Cai, Jianliang Huang, Zhongrui Su, Yuanzhen Yao, Fang Wen, Han Li, Yuxin Huang, Yi Zhao, Tao Xia, Mingsheng Lei, Weizhen Yang, Zhaowen Qiu |
| 92 |
[GO] |
2022―Mrz―08 |
Identifying SARS-CoV-2 Lineage Mutation Hallmarks and Correlating Them With Clinical Outcomes in Egypt: A Pilot Study |
Sara H. A. Agwa, Hesham Elghazaly, Mahmoud Shawky El Meteini, Yahia A. Yahia, Radwa Khaled, Aya M. Abd Elsamee, Reham M. Darwish, Shaimaa M. Elsayed, Hala Hafez, Basma S. Mahmoud, Fouda EM, Marwa Matboli |
| 93 |
[GO] |
2022―Feb―24 |
Significance of Cardiac Troponins as an Identification Tool in COVID-19 Patients Using Biosensors: An Update |
Yousef Rasmi, Osama F. Mosa, Shahriar Alipour, Nadia Heidari, Farzaneh Javanmard, Ali Golchin, Shiva Gholizadeh-Ghaleh Aziz |
| 94 |
[GO] |
2022―Feb―23 |
Changes of Small Non-coding RNAs by Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
Wenzhe Wu, Eun-Jin Choi, Binbin Wang, Ke Zhang, Awadalkareem Adam, Gengming Huang, Leo Tunkle, Philip Huang, Rohit Goru, Isabella Imirowicz, Leanne Henry, Inhan Lee, Jianli Dong, Tian Wang, Xiaoyong Bao |
| 95 |
[GO] |
2022―Feb―18 |
The Physical Basis for pH Sensitivity in Biomolecular Structure and Function, With Application to the Spike Protein of SARS-CoV-2 |
Jim Warwicker |
| 96 |
[GO] |
2022―Feb―14 |
SARS-CoV-2 Spike Protein Unlikely to Bind to Integrins via the Arg-Gly-Asp (RGD) Motif of the Receptor Binding Domain: Evidence From Structural Analysis and Microscale Accelerated Molecular Dynamics |
Houcemeddine Othman, Haifa Ben Messaoud, Oussema Khamessi, Hazem Ben-Mabrouk, Kais Ghedira, Avani Bharuthram, Florette Treurnicht, Ikechukwu Achilonu, Yasien Sayed, Najet Srairi-Abid |
| 97 |
[GO] |
2022―Feb―08 |
In Silico Infection Analysis (iSFA) Identified Coronavirus Infection and Potential Transmission Risk in Mammals |
Yanyan Zou, Xiaojian Cao, Bing Yang, Lulu Deng, Yangyang Xu, Shuang Dong, Wentao Li, Chengchao Wu, Gang Cao |
| 98 |
[GO] |
2022―Feb―04 |
Phytochemicals of Euphorbia hirta L. and Their Inhibitory Potential Against SARS-CoV-2 Main Protease |
Ruel Cayona, Evelyn Creencia |
| 99 |
[GO] |
2022―Feb―03 |
Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism |
Cecilia Calabrese, Anna Annunziata, Martina Flora, Domenica Francesca Mariniello, Valentino Allocca, Maria Ilaria Palma, Antonietta Coppola, Ilernando Meoli, Pia Clara Pafundi, Giuseppe Fiorentino |
| 100 |
[GO] |
2022―Feb―03 |
Susceptibility to Metabolic Diseases in COVID-19: To be or Not to be an Issue |
Maryam Kaviani, Somayeh Keshtkar, Saeede Soleimanian, Fatemeh Sabet Sarvestani, Negar Azarpira, Sara Pakbaz |
| 101 |
[GO] |
2022―Jan―28 |
Cancer Occurrence as the Upcoming Complications of COVID-19 |
Ilnaz Rahimmanesh, Laleh Shariati, Nasim Dana, Yasaman Esmaeili, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard |
| 102 |
[GO] |
2022―Jan―27 |
Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2 |
Suvro Biswas, Shafi Mahmud, Mohasana Akter Mita, Shamima Afrose, Md. Robiul Hasan, Mst. Sharmin Sultana Shimu, Md. Abu Saleh, Gomaa Mostafa-Hedeab, Mohammed Alqarni, Ahmad J. Obaidullah, Gaber El-Saber Batiha |
| 103 |
[GO] |
2022―Jan―24 |
A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease |
Jorge E. Hernández González, Raphael J. Eberle, Dieter Willbold, Mônika A. Coronado |
| 104 |
[GO] |
2022―Jan―18 |
The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2 |
Alexander A. Dolskiy, Andrey S. Gudymo, Oleg S. Taranov, Irina V. Grishchenko, Ekaterina M. Shitik, Dmitry Yu Prokopov, Vladislav O. Soldatov, Elvira V. Sobolevskaya, Sergey A. Bodnev, Natalia V. Danilchenko, Anastasia A. Moiseeva, Polina Y. Torzhkova, Yulia A. Bulanovich, Galina S. Onhonova, Elena K. Ivleva, Marina V. Kubekina, Andrey E. Belykh, Tatiana V. Tregubchak, Alexander B. Ryzhikov, Elena V. Gavrilova, Rinat A. Maksyutov, Alexey V. Deykin, Dmitry V. Yudkin |
| 105 |
[GO] |
2022―Jan―12 |
Molecular Mechanism of SARS-CoVs Orf6 Targeting the Rae1-Nup98 Complex to Compete With mRNA Nuclear Export |
Tinghan Li, Yibo Wen, Hangtian Guo, Tingting Yang, Haitao Yang, Xiaoyun Ji |
| 106 |
[GO] |
2022―Jan―11 |
CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2 |
Behrouz Shademan, Alireza Nourazarian, Saba Hajazimian, Alireza Isazadeh, Cigir Biray Avci, Mahin Ahangar Oskouee |
| 107 |
[GO] |
2022―Jan―03 |
The Oral Complications of COVID-19 |
Xinxuan Zhou, Jiajia Dong, Qiang Guo, Mingyun Li, Yan Li, Lei Cheng, Biao Ren |
| 108 |
[GO] |
2021―Dez―20 |
GSTP1 and GSTM3 Variant Alleles Affect Susceptibility and Severity of COVID-19 |
Vesna Coric, Ivana Milosevic, Tatjana Djukic, Zoran Bukumiric, Ana Savic-Radojevic, Marija Matic, Djurdja Jerotic, Nevena Todorovic, Milika Asanin, Marko Ercegovac, Jovan Ranin, Goran Stevanovic, Marija Pljesa-Ercegovac, Tatjana Simic |
| 109 |
[GO] |
2021―Dez―15 |
NCOA4-Mediated Ferritinophagy: A Vicious Culprit in COVID-19 Pathogenesis? |
Fengju Jia, Hongxia Liu, Shan Kang |
| 110 |
[GO] |
2021―Dez―13 |
Computational Insights Into the Effects of the R190K and N121Q Mutations on the SARS-CoV-2 Spike Complex With Biliverdin |
Zhiyuan Qu, Kaihang Li, Xiaoju Geng, Bo Huang, Jian Gao |
| 111 |
[GO] |
2021―Dez―09 |
Computational Saturation Mutagenesis of SARS-CoV-1 Spike Glycoprotein: Stability, Binding Affinity, and Comparison With SARS-CoV-2 |
Adebiyi Sobitan, Vidhyanand Mahase, Raina Rhoades, Dejaun Williams, Dongxiao Liu, Yixin Xie, Lin Li, Qiyi Tang, Shaolei Teng |
| 112 |
[GO] |
2021―Dez―02 |
Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients |
Franziska Schmelter, Bandik Föh, Alvaro Mallagaray, Johann Rahmöller, Marc Ehlers, Selina Lehrian, Vera von Kopylow, Inga Künsting, Anne Sophie Lixenfeld, Emily Martin, Mohab Ragab, Roza Meyer-Saraei, Fabian Kreutzmann, Ingo Eitel, Stefan Taube, Nadja Käding, Eckard Jantzen, Tobias Graf, Christian Sina, Ulrich L. Günther |
| 113 |
[GO] |
2021―Dez―01 |
Pleural Mesothelial Cells Modulate the Inflammatory/Profibrotic Response During SARS-CoV-2 Infection |
Giulia Matusali, Flavia Trionfetti, Veronica Bordoni, Roberta Nardacci, Laura Falasca, Daniele Colombo, Michela Terri, Claudia Montaldo, Concetta Castilletti, Davide Mariotti, Franca Del Nonno, Maria Rosaria Capobianchi, Chiara Agrati, Marco Tripodi, Raffaele Strippoli |
| 114 |
[GO] |
2021―Nov―08 |
Prediction of Non-canonical Routes for SARS-CoV-2 Infection in Human Placenta Cells |
Flávia Bessi Constantino, Sarah Santiloni Cury, Celia Regina Nogueira, Robson Francisco Carvalho, Luis Antonio Justulin |
| 115 |
[GO] |
2021―Okt―26 |
Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies |
Pek Yoon Chong, Jabed Iqbal, Joe Yeong, Tar Choon Aw, Kian Sing Chan, Paul Chui |
| 116 |
[GO] |
2021―Okt―25 |
SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan |
Adnan Khan, Muhammad Hanif, Akhtar Ahmed, Sarosh Syed, Saqib Ghazali, Rafiq Khanani |
| 117 |
[GO] |
2021―Okt―07 |
Respiratory Outcomes in Patients Following COVID-19-Related Hospitalization: A Meta-Analysis |
Tao Guo, Fangfang Jiang, Yufei Liu, Yunpeng Zhao, Yiran Li, Yihua Wang |
| 118 |
[GO] |
2021―Sep―21 |
ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology |
Yuexin Guo, Boya Wang, Han Gao, Lei Gao, Rongxuan Hua, Jing-Dong Xu |
| 119 |
[GO] |
2021―Sep―17 |
The Molecular Basis of Gender Variations in Mortality Rates Associated With the Novel Coronavirus (COVID-19) Outbreak |
Ibrahim Y. Hachim, Mahmood Y. Hachim, Iman Mamdouh Talaat, Vanessa M. López-Ozuna, Narjes Saheb Sharif-Askari, Saba Al Heialy, Rabih Halwani, Qutayba Hamid |
| 120 |
[GO] |
2021―Sep―07 |
Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19 |
Topu Raihan, Muhammad Fazle Rabbee, Puja Roy, Swapnila Choudhury, Kwang-Hyun Baek, Abul Kalam Azad |
| 121 |
[GO] |
2021―Sep―03 |
Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza |
Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, Sepideh Zununi Vahed, Mohammadreza Ardalan |
| 122 |
[GO] |
2021―Aug―20 |
Molecular Dynamics Simulations Reveal the Interaction Fingerprint of Remdesivir Triphosphate Pivotal in Allosteric Regulation of SARS-CoV-2 RdRp |
Mitul Srivastava, Lovika Mittal, Anita Kumari, Shailendra Asthana |
| 123 |
[GO] |
2021―Aug―12 |
DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2 |
Fabrizio Cleri, Marc F. Lensink, Ralf Blossey |
| 124 |
[GO] |
2021―Aug―05 |
Corrigendum: Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2 |
Perumal Gobinath, Ponnusamy Packialakshmi, Kaliappillai Vijayakumar, Magda H. Abdellattif, Mohd Shahbaaz, Akbar Idhayadhulla, Radhakrishnan Surendrakumar |
| 125 |
[GO] |
2021―Jul―28 |
SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development |
Yashpal S. Malik, Prashant Kumar, Mohd Ikram Ansari, Maged G. Hemida, Mohamed E. El Zowalaty, Ahmed S. Abdel-Moneim, Balasubramanian Ganesh, Sina Salajegheh, Senthilkumar Natesan, Shubhankar Sircar, Muhammad Safdar, O. R. Vinodhkumar, Phelipe M. Duarte, Shailesh K. Patel, Jörn Klein, Parastoo Rahimi, Kuldeep Dhama |
| 126 |
[GO] |
2021―Jul―27 |
Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation |
Yaoqiang Du, Hao Wang, Linjie Chen, Quan Fang, Biqin Zhang, Luxi Jiang, Zhaoyu Wu, Yexiaoqing Yang, Ying Zhou, Bingyu Chen, Jianxin Lyu, Zhen Wang |
| 127 |
[GO] |
2021―Jul―23 |
Evaluation and Comparison of Serological Methods for COVID-19 Diagnosis |
Fanwu Gong, Hua-xing Wei, Qiangsheng Li, Liu Liu, Bofeng Li |
| 128 |
[GO] |
2021―Jul―22 |
Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center |
David Barros Coelho, Vanessa Santos, David Araújo, Hélder Novais Bastos, Adriana Magalhães, Venceslau Hespanhol, Henrique Queiroga, Natália Cruz-Martins, Maria Gabriela O. Fernandes |
| 129 |
[GO] |
2021―Jul―21 |
The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge |
Yan-yan Yan, Wen-min Zhou, Yu-qing Wang, Qiao-ru Guo, Fu-xi Zhao, Zhuang-yan Zhu, Yan-xia Xing, Hai-yan Zhang, Mohamad Aljofan, Alireza Mosavi Jarrahi, Bolat Makabel, Jian-ye Zhang |
| 130 |
[GO] |
2021―Jul―20 |
A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19 |
Ruy Freitas Reis, Alexandre Bittencourt Pigozzo, Carla Rezende Barbosa Bonin, Barbara de Melo Quintela, Lara Turetta Pompei, Ana Carolina Vieira, Larissa de Lima e Silva, Maicom Peters Xavier, Rodrigo Weber dos Santos, Marcelo Lobosco |
| 131 |
[GO] |
2021―Jul―12 |
Correlation Analysis Between Serum Uric Acid, Prealbumin Level, Lactate Dehydrogenase, and Severity of COVID-19 |
Zhenmu Jin, Mo Zheng, Jichan Shi, Xinchun Ye, Fang Cheng, Que-Lu Chen, Jianping Huang, Xian-Gao Jiang |
| 132 |
[GO] |
2021―Jul―12 |
Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19 |
M. Ramesh, Krishnan Anand, Mohd Shahbaaz, Magda H. Abdellattif |
| 133 |
[GO] |
2021―Jul―12 |
Mathematical Model of SARS-Cov-2 Propagation Versus ACE2 Fits COVID-19 Lethality Across Age and Sex and Predicts That of SARS |
Ugo Bastolla |
| 134 |
[GO] |
2021―Jul―09 |
Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline |
Edmond Y. Lau, Oscar A. Negrete, W. F. Drew Bennett, Brian J. Bennion, Monica Borucki, Feliza Bourguet, Aidan Epstein, Magdalena Franco, Brooke Harmon, Stewart He, Derek Jones, Hyojin Kim, Daniel Kirshner, Victoria Lao, Jacky Lo, Kevin McLoughlin, Richard Mosesso, Deepa K. Murugesh, Edwin A. Saada, Brent Segelke, Maxwell A. Stefan, Garrett A. Stevenson, Marisa W. Torres, Dina R. Weilhammer, Sergio Wong, Yue Yang, Adam Zemla, Xiaohua Zhang, Fangqiang Zhu, Jonathan E. Allen, Felice C. Lightstone |
| 135 |
[GO] |
2021―Jul―05 |
In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19 |
Muthumanickam Sankar, Balajee Ramachandran, Boomi Pandi, Nachiappan Mutharasappan, Vidhyavathi Ramasamy, Poorani Gurumallesh Prabu, Gowrishankar Shanmugaraj, Yao Wang, Brintha Muniyandai, Subaskumar Rathinasamy, Balakumar Chandrasekaran, Mohammad F. Bayan, Jeyakanthan Jeyaraman, Gurumallesh Prabu Halliah, Solomon King Ebenezer |
| 136 |
[GO] |
2021―Jul―02 |
Indian Ethnomedicinal Phytochemicals as Promising Inhibitors of RNA-Binding Domain of SARS-CoV-2 Nucleocapsid Phosphoprotein: An In Silico Study |
Sankar Muthumanickam, Arumugam Kamaladevi, Pandi Boomi, Shanmugaraj Gowrishankar, Shunmugiah Karutha Pandian |
| 137 |
[GO] |
2021―Jul―01 |
Management and Thinking on the Treatment of Cancer Patients During the COVID-19 |
Shuangyue Pan, Jiahong Jiang, Zheling Chen, Liu Yang |
| 138 |
[GO] |
2021―Jun―30 |
The Role of Indoor Plants in air Purification and Human Health in the Context of COVID-19 Pandemic: A Proposal for a Novel Line of Inquiry |
Rania El-Tanbouly, Ziad Hassan, Sarah El-Messeiry |
| 139 |
[GO] |
2021―Jun―21 |
Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2 |
Santosh K. Ghosh, Aaron Weinberg |
| 140 |
[GO] |
2021―Jun―11 |
Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer |
Jingwen Yue, Weihua Jin, Hua Yang, John Faulkner, Xuehong Song, Hong Qiu, Michael Teng, Parastoo Azadi, Fuming Zhang, Robert J. Linhardt, Lianchun Wang |
| 141 |
[GO] |
2021―Jun―09 |
A Minireview of the Promising Drugs and Vaccines in Pipeline for the Treatment of COVID-19 and Current Update on Clinical Trials |
Jeyanthi Venkadapathi, Venkat Kumar Govindarajan, Saravanan Sekaran, Santhi Venkatapathy |
| 142 |
[GO] |
2021―Jun―09 |
In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2 |
Edoardo Milanetti, Mattia Miotto, Lorenzo Di Rienzo, Madhu Nagaraj, Michele Monti, Thaddeus W. Golbek, Giorgio Gosti, Steven J. Roeters, Tobias Weidner, Daniel E. Otzen, Giancarlo Ruocco |
| 143 |
[GO] |
2021―Jun―04 |
Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients |
Hongliang Zhang, Yujie Tang, Jinhui Tao |
| 144 |
[GO] |
2021―Mai―31 |
Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection |
Arnaud John Kombe Kombe, Ayesha Zahid, Ahmed Mohammed, Ronghua Shi, Tengchuan Jin |
| 145 |
[GO] |
2021―Mai―26 |
Initial PCR Testing Negative, but Chest CT Suggesting for Viral Pneumonia Urges for Repeated Testing for COVID-19 Diagnosis |
Lingwei Wang, Danting Zhan, Xiaodi Liu, Kai Yang, Shipin Wu, Heng Zhang, Min Yu, Yimin Zha, Weibin Huang, Lei Li, Rongchang Chen, Chen Qiu |
| 146 |
[GO] |
2021―Mai―26 |
Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach |
Mycal Dutta, Mohammad Nezam, Subrata Chowdhury, Ahmed Rakib, Arkajyoti Paul, Saad Ahmed Sami, Md. Zia Uddin, Md. Sohel Rana, Shahadat Hossain, Yunus Effendi, Rinaldi Idroes, Trina Tallei, Ali M. Alqahtani, Talha Bin Emran |
| 147 |
[GO] |
2021―Mai―24 |
The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19 |
Hao Li, Jianmin Li, Wei Xiao, Yujing Zhang, Yuan Lv, Xing Yu, Jiao Zheng |
| 148 |
[GO] |
2021―Mai―24 |
Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study |
Sonia Beeckmans, Edilbert Van Driessche |
| 149 |
[GO] |
2021―Mai―17 |
An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease |
Tianhua Zhai, Fangyuan Zhang, Shozeb Haider, Daniel Kraut, Zuyi Huang |
| 150 |
[GO] |
2021―Mai―13 |
Current Strategies of Antiviral Drug Discovery for COVID-19 |
Miao Mei, Xu Tan |
| 151 |
[GO] |
2021―Mai―11 |
Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2 |
Perumal Gobinath, Ponnusamy Packialakshmi, Daoud Ali, Saud Alarifi, Amal Alotaibi, Akbar Idhayadhulla, Radhakrishnan Surendrakumar |
| 152 |
[GO] |
2021―Mai―10 |
Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2 |
Shafi Mahmud, Gobindo Kumar Paul, Suvro Biswas, Shamima Afrose, Mohasana Akter Mita, Md. Robiul Hasan, Mst. Sharmin Sultana Shimu, Alomgir Hossain, Maria Meha Promi, Fahmida Khan Ema, Kumarappan Chidambaram, Balakumar Chandrasekaran, Ali M. Alqahtani, Talha Bin Emran, Md. Abu Saleh |
| 153 |
[GO] |
2021―Mai―10 |
Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications |
Nadide Altincekic, Sophie Marianne Korn, Nusrat Shahin Qureshi, Marie Dujardin, Martí Ninot-Pedrosa, Rupert Abele, Marie Jose Abi Saad, Caterina Alfano, Fabio C. L. Almeida, Islam Alshamleh, Gisele Cardoso de Amorim, Thomas K. Anderson, Cristiane D. Anobom, Chelsea Anorma, Jasleen Kaur Bains, Adriaan Bax, Martin Blackledge, Julius Blechar, Anja Böckmann, Louis Brigandat, Anna Bula, Matthias Bütikofer, Aldo R. Camacho-Zarco, Teresa Carlomagno, Icaro Putinhon Caruso, Betül Ceylan, Apirat Chaikuad, Feixia Chu, Laura Cole, Marquise G. Crosby, Vanessa de Jesus, Karthikeyan Dhamotharan, Isabella C. Felli, Jan Ferner, Yanick Fleischmann, Marie-Laure Fogeron, Nikolaos K. Fourkiotis, Christin Fuks, Boris Fürtig, Angelo Gallo, Santosh L. Gande, Juan Atilio Gerez, Dhiman Ghosh, Francisco Gomes-Neto, Oksana Gorbatyuk, Serafima Guseva, Carolin Hacker, Sabine Häfner, Bing Hao, Bruno Hargittay, K. Henzler-Wildman, Jeffrey C. Hoch, Katharina F. Hohmann, Marie T. Hutchison, Kristaps Jaudzems, Katarina Jović, Janina Kaderli, Gints Kalniņš, Iveta Kaņepe, Robert N. Kirchdoerfer, John Kirkpatrick, Stefan Knapp, Robin Krishnathas, Felicitas Kutz, Susanne zur Lage, Roderick Lambertz, Andras Lang, Douglas Laurents, Lauriane Lecoq, Verena Linhard, Frank Löhr, Anas Malki, Luiza Mamigonian Bessa, Rachel W. Martin, Tobias Matzel, Damien Maurin, Seth W. McNutt, Nathane Cunha Mebus-Antunes, Beat H. Meier, Nathalie Meiser, Miguel Mompeán, Elisa Monaca, Roland Montserret, Laura Mariño Perez, Celine Moser, Claudia Muhle-Goll, Thais Cristtina Neves-Martins, Xiamonin Ni, Brenna Norton-Baker, Roberta Pierattelli, Letizia Pontoriero, Yulia Pustovalova, Oliver Ohlenschläger, Julien Orts, Andrea T. Da Poian, Dennis J. Pyper, Christian Richter, Roland Riek, Chad M. Rienstra, Angus Robertson, Anderson S. Pinheiro, Raffaele Sabbatella, Nicola Salvi, Krishna Saxena, Linda Schulte, Marco Schiavina, Harald Schwalbe, Mara Silber, Marcius da Silva Almeida, Marc A. Sprague-Piercy, Georgios A. Spyroulias, Sridhar Sreeramulu, Jan-Niklas Tants, Kaspars Tārs, Felix Torres, Sabrina Töws, Miguel Á. Treviño, Sven Trucks, Aikaterini C. Tsika, Krisztina Varga, Ying Wang, Marco E. Weber, Julia E. Weigand, Christoph Wiedemann, Julia Wirmer-Bartoschek, Maria Alexandra Wirtz Martin, Johannes Zehnder, Martin Hengesbach, Andreas Schlundt |
| 154 |
[GO] |
2021―Mai―05 |
A Strategy Based on Loop Analysis to Develop Peptide Epitopes: Application to SARS-CoV-2 Spike Protein |
Maria Luisa Di Vona, Gian Maria Rossolini, Marco Sette |
| 155 |
[GO] |
2021―Apr―22 |
Antibodies and Vaccines Target RBD of SARS-CoV-2 |
Long Min, Qiu Sun |
| 156 |
[GO] |
2021―Apr―20 |
Impact of Ribosome Activity on SARS-CoV-2 LNP - Based mRNA Vaccines |
Evangelos Tsiambas, Aristeidis Chrysovergis, Vasileios Papanikolaou, Nicholas Mastronikolis, Vasileios Ragos, Anna Batistatou, Dimitrios Peschos, Nikolaos Kavantzas, Andreas C. Lazaris, Efthimios Kyrodimos |
| 157 |
[GO] |
2021―Apr―15 |
Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19 |
Rajashri Bezbaruah, Pobitra Borah, Bibhuti Bhushan Kakoti, Nizar A. Al-Shar’I, Balakumar Chandrasekaran, Da’san M. M. Jaradat, Munir A. Al-Zeer, Saeid Abu-Romman |
| 158 |
[GO] |
2021―Apr―15 |
Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6 |
Pan Li, Zhengmao Lu, Qiang Li, Zhenmeng Wang, Yan Guo, Chen Cai, Shengyun Wang, Peng Liu, Xiaoping Su, Yi Huang, Yuchao Dong, Wenjuan Qiu, Yueming Ling, Lonny Yarmus, Fengming Luo, Li Zeng, Chong Bai, Wei Zhang |
| 159 |
[GO] |
2021―Apr―13 |
High-Flow Nasal Cannula for COVID-19 Patients: A Multicenter Retrospective Study in China |
Jun Duan, Jia Zeng, Puyu Deng, Zhong Ni, Rongli Lu, Wenxi Xia, Guoqiang Jing, Xiaoping Su, Stephan Ehrmann, Wei Zhang, Jie Li |
| 160 |
[GO] |
2021―Apr―13 |
Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production |
Xiaohui Zhao, Huan Chen, Hongliang Wang |
| 161 |
[GO] |
2021―Apr―12 |
Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19 |
Yun Yang, Weishan Huang, Yubo Fan, Guo-Qiang Chen |
| 162 |
[GO] |
2021―Apr―12 |
Inhibition of SARS-CoV-2 3CL Mpro by Natural and Synthetic Inhibitors: Potential Implication for Vaccine Production Against COVID-19 |
Anwar Ullah, Kifayat Ullah |
| 163 |
[GO] |
2021―Apr―12 |
The Deadly Duo of COVID-19 and Cancer! |
Vivek R. Bora, Bhoomika M. Patel |
| 164 |
[GO] |
2021―Apr―09 |
Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2 |
Thirumal Kumar D, Nishaat Shaikh, Udhaya Kumar S, George Priya Doss C, Hatem Zayed |
| 165 |
[GO] |
2021―Mrz―31 |
A Multifunctional Peptide From Bacillus Fermented Soybean for Effective Inhibition of SARS-CoV-2 S1 Receptor Binding Domain and Modulation of Toll Like Receptor 4: A Molecular Docking Study |
Srichandan Padhi, Samurailatpam Sanjukta, Rounak Chourasia, Rajendra K. Labala, Sudhir P. Singh, Amit K. Rai |
| 166 |
[GO] |
2021―Mrz―30 |
Chest CT Images for COVID-19: Radiologists and Computer-Based Detection |
Qingli Dou, Jiangping Liu, Wenwu Zhang, Yanan Gu, Wan-Ting Hsu, Kuan-Ching Ho, Hoi Sin Tong, Wing Yan Yu, Chien-Chang Lee |
| 167 |
[GO] |
2021―Mrz―25 |
Perspectives on RNA Vaccine Candidates for COVID-19 |
Pobitra Borah, Pran Kishore Deb, Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Katharigatta N. Venugopala, Vinayak Singh, Pottathil Shinu, Snawar Hussain, Satyendra Deka, Balakumar Chandrasekaran, Da’san M. M. Jaradat |
| 168 |
[GO] |
2021―Mrz―18 |
Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression |
Etienne Cavalier, Julien Guiot, Katharina Lechner, Alexander Dutsch, Mark Eccleston, Marielle Herzog, Thomas Bygott, Adrian Schomburg, Theresa Kelly, Stefan Holdenrieder |
| 169 |
[GO] |
2021―Mrz―16 |
An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome-Coronavirus |
Muthu Kumaradoss Kathiravan, Srimathi Radhakrishnan, Vigneshwaran Namasivayam, Senthilkumar Palaniappan |
| 170 |
[GO] |
2021―Mrz―08 |
Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives |
Karthik Vivekanandhan, Poornima Shanmugam, Hamed Barabadi, Vigneshwaran Arumugam, Dharun Daniel Raj Daniel Paul Raj, Manikandan Sivasubramanian, Subbaiya Ramasamy, Krishnan Anand, Pandi Boomi, Balakumar Chandrasekaran, Selvaraj Arokiyaraj, Muthupandian Saravanan |
| 171 |
[GO] |
2021―Feb―26 |
Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection |
Biswa Mohan Sahoo, B. V. V. Ravi Kumar, J. Sruti, Manoj Kumar Mahapatra, Bimal K. Banik, Preetismita Borah |
| 172 |
[GO] |
2021―Feb―22 |
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection |
Elettra Barberis, Virginia V. Vanella, Marco Falasca, Valeria Caneapero, Giuseppe Cappellano, Davide Raineri, Marco Ghirimoldi, Veronica De Giorgis, Chiara Puricelli, Rosanna Vaschetto, Pier Paolo Sainaghi, Stefania Bruno, Antonio Sica, Umberto Dianzani, Roberta Rolla, Annalisa Chiocchetti, Vincenzo Cantaluppi, Gianluca Baldanzi, Emilio Marengo, Marcello Manfredi |
| 173 |
[GO] |
2021―Feb―20 |
Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted |
Pobitra Borah, Pran Kishore Deb, Balakumar Chandrasekaran, Manoj Goyal, Monika Bansal, Snawar Hussain, Pottathil Shinu, Katharigatta N. Venugopala, Nizar A. Al-Shar’i, Satyendra Deka, Vinayak Singh |
| 174 |
[GO] |
2021―Feb―15 |
Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin |
Mattia Miotto, Lorenzo Di Rienzo, Leonardo Bò, Alberto Boffi, Giancarlo Ruocco, Edoardo Milanetti |
| 175 |
[GO] |
2021―Feb―08 |
New Insights Into Potential Benefits of Bioactive Compounds of Bee Products on COVID-19: A Review and Assessment of Recent Research |
Ehab Kotb Elmahallawy, Yasser Mohamed, Walied Abdo, Fatma A. El-Gohary, Shaimaa Ahmed Awad Ali, Tokuma Yanai |
| 176 |
[GO] |
2021―Feb―04 |
Therapeutic Strategies in the Management of COVID-19 |
Rajashri R. Naik, Ashok K. Shakya |
| 177 |
[GO] |
2021―Jan―27 |
SARS-CoV-2 Proteins Exploit Host’s Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways |
Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam |
| 178 |
[GO] |
2021―Jan―25 |
Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic |
Mingjia Yu, Tianji Zhang, Wei Zhang, Qianyun Sun, Hongmei Li, Jin-ping Li |
| 179 |
[GO] |
2021―Jan―25 |
A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic |
Tofael Ahmed Sumon, Md. Ashraf Hussain, Md. Tawheed Hasan, Mahmudul Hasan, Won Je Jang, Eleus Hussain Bhuiya, Abdullah Al Mamun Chowdhury, S. M. Sharifuzzaman, Christopher Lyon Brown, Hyun-Ju Kwon, Eun-Woo Lee |
| 180 |
[GO] |
2021―Jan―19 |
In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19 |
Divya M. Teli, Mamta B. Shah, Mahesh T. Chhabria |
| 181 |
[GO] |
2021―Jan―14 |
In vitro Dissolution Profile at Different Biological pH Conditions of Hydroxychloroquine Sulfate Tablets Is Available for the Treatment of COVID-19 |
Thirupathi Dongala, Naresh Kumar Katari, Santhosh Kumar Ettaboina, Anand Krishnan, Murtaza M. Tambuwala, Kamal Dua |
| 182 |
[GO] |
2021―Jan―13 |
Characteristics of COVID-19 Patients Based on the Results of Nucleic Acid and Specific Antibodies and the Clinical Relevance of Antibody Levels |
Hao Chen, Rundong Qin, Zhifeng Huang, Li He, Wenting Luo, Peiyan Zheng, Huimin Huang, Hui Wang, Baoqing Sun |
| 183 |
[GO] |
2021―Jan―13 |
SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells |
Shiv Bharadwaj, Mahendra Singh, Nikhil Kirtipal, Sang Gu Kang |
| 184 |
[GO] |
2021―Jan―07 |
Exploring the Potential of Carbon Dots to Combat COVID-19 |
Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Nabil A. Alhakamy, Shadab Md, Anroop B. Nair, Pran Kishore Deb |
| 185 |
[GO] |
2021―Jan―07 |
The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic |
Ludwig Aigner, Frank Pietrantonio, Diana Marisa Bessa de Sousa, Johanna Michael, Daniela Schuster, Herbert Anton Reitsamer, Horst Zerbe, Michael Studnicka |
| 186 |
[GO] |
2021―Jan―07 |
Molecular Docking and Molecular Dynamics Aided Virtual Search of OliveNet™ Directory for Secoiridoids to Combat SARS-CoV-2 Infection and Associated Hyperinflammatory Responses |
Neelaveni Thangavel, Mohammad Al Bratty, Hassan Ahmad Al Hazmi, Asim Najmi, Reem Othman Ali Alaqi |
| 187 |
[GO] |
2020―Dez―23 |
Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CLpro |
Savariar Vincent, Selvaraj Arokiyaraj, Muthupandian Saravanan, Manoj Dhanraj |
| 188 |
[GO] |
2020―Dez―23 |
Visual Detection of SARS-CoV-2 RNA by Conventional PCR-Induced Generation of DNAzyme Sensor |
Anbalagan Anantharaj, Soon Jyoti Das, Patil Sharanabasava, Rakesh Lodha, Sushil K. Kabra, Tarun Kumar Sharma, Guruprasad R. Medigeshi |
| 189 |
[GO] |
2020―Dez―18 |
Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line |
Alexander A. Dolskiy, Sergei A. Bodnev, Anastasia A. Nazarenko, Anastasia M. Smirnova, Olga G. Pyankova, Anna K. Matveeva, Irina V. Grishchenko, Tatiana V. Tregubchak, Oleg V. Pyankov, Alexander B. Ryzhikov, Elena V. Gavrilova, Rinat A. Maksyutov, Dmitry V. Yudkin |
| 190 |
[GO] |
2020―Dez―18 |
Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening |
Ashraf Ahmed Ali Abdusalam, Vikneswaran Murugaiyah |
| 191 |
[GO] |
2020―Dez―18 |
Surveying the Side-Chain Network Approach to Protein Structure and Dynamics: The SARS-CoV-2 Spike Protein as an Illustrative Case |
Anushka Halder, Arinnia Anto, Varsha Subramanyan, Moitrayee Bhattacharyya, Smitha Vishveshwara, Saraswathi Vishveshwara |
| 192 |
[GO] |
2020―Dez―17 |
Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be |
Giuseppina Mariano, Rebecca J. Farthing, Shamar L. M. Lale-Farjat, Julien R. C. Bergeron |
| 193 |
[GO] |
2020―Dez―14 |
Potential Mechanisms for Traditional Chinese Medicine in Treating Airway Mucus Hypersecretion Associated With Coronavirus Disease 2019 |
Yuanfeng Zhang, Zheyi Wang, Yue Zhang, Hongxuan Tong, Yiling Zhang, Tao Lu |
| 194 |
[GO] |
2020―Dez―11 |
A Potential Peptide From Soy Cheese Produced Using Lactobacillus delbrueckii WS4 for Effective Inhibition of SARS-CoV-2 Main Protease and S1 Glycoprotein |
Rounak Chourasia, Srichandan Padhi, Loreni Chiring Phukon, Md Minhajul Abedin, Sudhir P. Singh, Amit Kumar Rai |
| 195 |
[GO] |
2020―Dez―11 |
Fetal Metabolomic Alterations Following Porcine Reproductive and Respiratory Syndrome Virus Infection |
Carolina M. Malgarin, Daniel J. MacPhee, John C. S. Harding |
| 196 |
[GO] |
2020―Dez―09 |
Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2 |
Yixin Xie, Chitra B. Karki, Dan Du, Haotian Li, Jun Wang, Adebiyi Sobitan, Shaolei Teng, Qiyi Tang, Lin Li |
| 197 |
[GO] |
2020―Dez―04 |
Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19 |
Wen Cui, Kailin Yang, Haitao Yang |
| 198 |
[GO] |
2020―Nov―24 |
Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM |
Md Fulbabu Sk, Nisha Amarnath Jonniya, Rajarshi Roy, Sayan Poddar, Parimal Kar |
| 199 |
[GO] |
2020―Nov―20 |
Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections |
Satyendra C. Tripathi, Vishwajit Deshmukh, Chad J. Creighton, Ashlesh Patil |
| 200 |
[GO] |
2020―Nov―17 |
Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives |
Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Nabil Abdulhafiz Alhakamy, Shadab Md, Anroop B. Nair, Pran Kishore Deb |
| 201 |
[GO] |
2020―Okt―23 |
Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis |
Jukun Song, Jing Han, Feng Liu, Xianlin Chen, Shenqi Qian, Yadong Wang, Zhenyu Jia, Xiaofeng Duan, Xiangyan Zhang, Jianguo Zhu |
| 202 |
[GO] |
2020―Okt―16 |
Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues |
Qiushi Feng, Lin Li, Xiaosheng Wang |
| 203 |
[GO] |
2020―Okt―16 |
Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations |
Soumya Lipsa Rath, Kishant Kumar |
| 204 |
[GO] |
2020―Okt―15 |
Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches |
Muhammad Waqas, Ali Haider, Muhammad Sufyan, Sami Siraj, Sheikh Arslan Sehgal |
| 205 |
[GO] |
2020―Okt―14 |
COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response |
Sanchit Seth, Jyotsna Batra, Srilakshmi Srinivasan |
| 206 |
[GO] |
2020―Okt―08 |
ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection? |
Francesca Pagliari, Maria Grazia Marafioti, Geraldine Genard, Patrizio Candeloro, Giuseppe Viglietto, Joao Seco, Luca Tirinato |
| 207 |
[GO] |
2020―Sep―30 |
Discovery of Potential Flavonoid Inhibitors Against COVID-19 3CL Proteinase Based on Virtual Screening Strategy |
Zhongren Xu, Lixiang Yang, Xinghao Zhang, Qiling Zhang, Zhibin Yang, Yuanhao Liu, Shuang Wei, Wukun Liu |
| 208 |
[GO] |
2020―Sep―30 |
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives |
Federica Saponaro, Grazia Rutigliano, Simona Sestito, Lavinia Bandini, Barbara Storti, Ranieri Bizzarri, Riccardo Zucchi |
| 209 |
[GO] |
2020―Sep―23 |
Computational Study of the Ion and Water Permeation and Transport Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel |
Yipeng Cao, Rui Yang, Wei Wang, Imshik Lee, Ruiping Zhang, Wenwen Zhang, Jiana Sun, Bo Xu, Xiangfei Meng |
| 210 |
[GO] |
2020―Sep―18 |
SARS-CoV-2 Virion Stabilization by Zn Binding |
Silvia Morante, Giovanni La Penna, Giancarlo Rossi, Francesco Stellato |
| 211 |
[GO] |
2020―Sep―10 |
Can CRISPR/Cas Technology Be a Felicitous Stratagem Against the COVID-19 Fiasco? Prospects and Hitches |
Rocktotpal Konwarh |
| 212 |
[GO] |
2020―Sep―01 |
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses |
Luca Vangelista, Massimiliano Secchi |
| 213 |
[GO] |
2020―Aug―25 |
Drug Weaponry to Fight Against SARS-CoV-2 |
Elena Cabezón, Ignacio Arechaga |
| 214 |
[GO] |
2020―Aug―21 |
SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle |
Eleni Nikolakaki, Thomas Giannakouros |
| 215 |
[GO] |
2020―Aug―21 |
Bioactive Virus-Mimicking Nanovesicles From Dendrimersomes: A Novel Approach to Understanding SARS-CoV-2 Host-Interactions to Better Design Therapeutics |
Bilal Javed |
| 216 |
[GO] |
2020―Aug―11 |
Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19 |
Swapan K. Chatterjee, Snigdha Saha, Maria Nilda M. Munoz |
| 217 |
[GO] |
2020―Aug―11 |
COVID-19: Looking Into the Overlooked |
Fernanda Cristina Petersen, Ulf Reidar Dahle, Belinda Nicolau, Climent Casals-Pascual |
| 218 |
[GO] |
2020―Aug―07 |
Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19 |
Navin Kumar Verma, Mobashar Hussain Urf Turabe Fazil, Shane P. Duggan, Dermot Kelleher |
| 219 |
[GO] |
2020―Aug―04 |
Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease |
Yuliana K. Bosken, Timothy Cholko, Yuan-Chao Lou, Kuen-Phon Wu, Chia-en A. Chang |
| 220 |
[GO] |
2020―Aug―03 |
A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment |
Luciano Pirone, Annarita Del Gatto, Sonia Di Gaetano, Michele Saviano, Domenica Capasso, Laura Zaccaro, Emilia Pedone |
| 221 |
[GO] |
2020―Jul―03 |
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19 |
Bicheng Zhang, Xiaoyang Zhou, Chengliang Zhu, Yuxiao Song, Fan Feng, Yanru Qiu, Jia Feng, Qingzhu Jia, Qibin Song, Bo Zhu, Jun Wang |
| 222 |
[GO] |
2020―Jun―05 |
Does Early Childhood Vaccination Protect Against COVID-19? |
Karzan R. Sidiq, Dana Khdr Sabir, Shakhawan M. Ali, Rimantas Kodzius |
|
